Company lists · Data refreshed September 2026
Top 25 Immunotherapy venture capital companies based in the United Kingdom
RevenueBase identified 77 company matches for immunotherapy venture capital companies associated with the United Kingdom as of September 2026 and tracks 2,304 professional contacts across them, including 1,356 with verified work emails and 244 with mobile numbers. London is the largest hub.
This list covers company matches for immunotherapy venture capital companies associated with the United Kingdom, found by RevenueBase SmartSearch using the meaning of business descriptions in its company graph at Exact. Ranked by professionals tracked, largest first. Rows show recorded descriptions where available, Exact search membership and the snapshot date. Data refreshed September 3, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase SmartSearch, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 25 largest immunotherapy venture capital companies based in the United Kingdom
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | 763 contacts → | ||||
Exact match “Autolus is a CAR T cell therapy company.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 2 | 349 contacts → | ||||
Exact match “Allergy Therapeutics is a visionary immunology business with specialist experience in the research and development of allergy treatments.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 3 | 157 contacts → | ||||
Exact match “An exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 4 | 63 contacts → | ||||
Exact match “Enara Bio is shining a light on Dark Antigen and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients…” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 5 | 63 contacts → | ||||
Exact match “Achilles Therapeutics’ mission is to develop next-generation, patient-specific therapies that harness the immune system to destroy cancer cells.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 6 | 61 contacts → | ||||
Exact match “T-Therapeutics is a next-generation TCR company, spun out from the University of Cambridge, deeply rooted in world-leading academic science.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 7 | 59 contacts → | ||||
Exact match “Oxford BioTherapeutics (OBT) is a clinical stage oncology company based in Oxford, UK; San Jose, CA and Morristown, NJ, USA, with a pipeline of first-in-class immuno-oncology (IO)…” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 8 | 52 contacts → | ||||
Exact match “Scancell is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 9 | 51 contacts → | ||||
Exact match “Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 10 | 36 contacts → | ||||
Exact match “Gylden is a clinical-stage, privately held biotechnology company, headquartered in Abingdon, Oxfordshire, UK, with R&D and GMP manufacturing facilities in Milton Park…” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 11 | 32 contacts → | ||||
Exact match “Infinitopes is a pioneer in precision immunomics medicines.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 12 | 28 contacts → | ||||
Exact match “TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing…” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 13 | 27 contacts → | ||||
Exact match “Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 14 | 22 contacts → | ||||
Exact match “Centauri Therapeutics Limited is a UK-based biotechnology company focused on the discovery and development of novel molecules targeting life threatening diseases.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 15 | 22 contacts → | ||||
Exact match “Yellowstone aims to unlock a new class of therapeutically targetable frequently expressed antigens with potential to significantly transform patient lives.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 16 | 21 contacts → | ||||
Exact match “Leucid is progressing novel CAR T therapies that produce a better and more durable response than previous CAR T generations, improving treatment outcomes and saving the lives of…” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 17 | 20 contacts → | ||||
Exact match “LIFT BioSciences is pioneering a new class of immunotherapy for hard-to-treat cancers based on allogeneic Immuno-Modulatory Alpha Neutrophils (IMANs)®.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 18 | 19 contacts → | ||||
Exact match “Prokarium is pioneering the field of microbial immunotherapy.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 19 | 18 contacts → | ||||
Exact match “Broadening cancer patient access to powerful disease-transforming immunotherapy.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 20 | 18 contacts → | ||||
Exact match “Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 21 | 17 contacts → | ||||
Exact match “Cumulus Oncology is developing anti-cancer therapies for clinical settings in areas of high unmet need, with the aim of developing improved outcomes for cancer patients.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 22 | 16 contacts → | ||||
Exact match “4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 23 | 16 contacts → | ||||
Exact match “RQ Biotechnology is making instant immunity a reality for vulnerable people.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 24 | 15 contacts → | ||||
Exact match “Exogene is an Oxford-based, venture-backed biotechnology company using a proprietary lab-in-the-loop AI platform to design novel, multi-specific immune engager drugs targeting…” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
| 25 | 13 contacts → | ||||
Exact match “Poolbeg Pharma plc (AIM: POLB) is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field.” Recorded in the RevenueBase company graph · Sep 3, 2026 · View company records in RevenueBase | |||||
RevenueBase SmartSearch
Describe a niche business in your own words. RevenueBase SmartSearch compares the meaning of your description with company business descriptions compiled in the RevenueBase company graph. Exact, Similar, Related and Broad control how closely companies must fit.
This list uses Exact for “immunotherapy venture capital companies”. Each Exact match badge shows membership in that saved search; it is not an individual similarity score or a service-quality rating. Recorded descriptions are shown where available.
Showing 25 of 77 immunotherapy venture capital companies based in the United Kingdom
See the full list, filter by size, metro and specialty, and access 1,356 tracked professional contacts with verified work emails. Direct dials are available where recorded.
Free signup · no credit card
Immunotherapy venture capital companies based in the United Kingdom at a glance
As of Sep 3, 2026Companies by employee count
Freshness & accuracy
How recently the business emails on this list were verified
Email last verified
How this list was built
The recorded descriptions help you assess these company matches. Check a company’s website for its current services and locations.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase SmartSearch, the natural-language company search available to every RevenueBase user.
- What qualifies
- Company records associated with the United Kingdom whose business descriptions match “immunotherapy venture capital companies” by meaning at the Exact setting. Descriptions are compiled in the RevenueBase company graph from public websites, profiles and company information where available; they are not guaranteed quotations from the company's website.
- RevenueBase SmartSearch
- Describe a niche company in your own words to find businesses by meaning. Exact, Similar, Related and Broad control the breadth of RevenueBase SmartSearch. This saved list uses Exact. Each row's Exact match badge shows inclusion in that search, not an individual score or a service-quality judgment.
- Public preview
- The public preview omits records without a verified work email. Where headquarters information is recorded, preview rows are also filtered to this page’s location. Dataset totals and geographic summaries describe the full matched records before these preview filters.
- Match quality
- RevenueBase's August 25, 2026 study assessed 4,198 description/company pairs across matching settings. The publisher reports 86% good or better at Exact. This evaluates the method across queries; it does not audit this individual list. Recorded company descriptions, where available, help you judge each match yourself. Read the full methodology: how the lists are built and what the study measures.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every displayed company carries at least one verified work email. RevenueBase tracks 1,356 professional contacts with verified work emails across the full matched dataset. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 3, 2026. Lists refresh periodically as the graph is re-checked.
- Record context
- Company records and descriptions can change. Check the company's website for its current services and locations.
Immunotherapy venture capital companies by metro
Frequently asked
What is RevenueBase SmartSearch?
RevenueBase SmartSearch finds niche companies by the meaning of their business descriptions in the RevenueBase company graph. Exact, Similar, Related and Broad control how closely companies must fit your description. This list uses Exact for “immunotherapy venture capital companies”; each Exact match badge shows search membership, not an individual similarity or quality score.
How many immunotherapy venture capital companies are there based in the United Kingdom?
RevenueBase identified 77 company matches for immunotherapy venture capital companies associated with the United Kingdom as of September 2026, using the meaning of business descriptions at Exact. This is the recorded matched set in the RevenueBase company graph.
What is the largest company on this list?
Autolus Therapeutics tops the displayed preview by professional contacts tracked in RevenueBase. Recorded headquarters appear in the company rows.
Which city has the most immunotherapy venture capital companies?
London leads with 37 company records, followed by Oxford (13) and Cambridge (6).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work limited free results with 500 credits to start. Upgrading provides access to the 1,356 professional contacts with verified work emails tracked across these 77 companies; direct dials are available where recorded.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 3, 2026.
Ready to reach these companies? Verified emails and direct dials for all 77 immunotherapy venture capital companies based in the United Kingdom. Start with a free account, no credit card.
Download this list →Related lists
Immunotherapy venture capital companies by geography
- Immunotherapy venture capital companies based in the United States
- Immunotherapy venture capital companies based in France
- Immunotherapy venture capital companies based in Germany
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland
- Immunotherapy venture capital companies based in Australia
- Immunotherapy venture capital companies based in Spain
- Immunotherapy venture capital companies based in London, United Kingdom
- Immunotherapy venture capital companies based in Boston, United States
- Immunotherapy venture capital companies based in Cambridge, United States
- Immunotherapy venture capital companies based in New York, United States
- Immunotherapy venture capital companies based in San Diego, United States
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase SmartSearch, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Immunotherapy venture capital companies based in the United States
- Immunotherapy venture capital companies based in France
- Immunotherapy venture capital companies based in Germany
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland
- Immunotherapy venture capital companies based in Australia
Company intelligence · public preview
Top 25 immunotherapy venture capital companies based in the United Kingdom
Find companies in any niche.
Describe the businesses you want in your own words. RevenueBase SmartSearch matches company descriptions by meaning.
RevenueBase records 77 matching company records for immunotherapy venture capital companies based in the United Kingdom, with 2,304 tracked contacts and 1,356 verified work emails.
This public preview shows 25 selected records ordered by tracked contacts. RevenueBase SmartSearch finds company descriptions that match by meaning at Exact. Snapshot: September 3, 2026.
RevenueBase compiles business descriptions for niche-company discovery; each row shows a recorded excerpt where available. Adapt this search to find the companies and contacts you want.
Top 25 immunotherapy venture capital companies based in the United Kingdom
The public list shows selected company records with contact and verified-email coverage. Reported employee bands provide separate company-size context.
| # | Company | Headquarters on record | Reported employees | RevenueBase SmartSearch | Tracked contacts |
|---|---|---|---|---|---|
| 1 |  Autolus Therapeuticsautolus.comHQ: London, United KingdomReported employees: 501-1,000 | London, United Kingdom | 501-1,000 | Exact match | 763 contacts → |
“Autolus is a CAR T cell therapy company.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 2 |  Allergy Therapeuticsallergytherapeutics.comHQ: Worthing, United KingdomReported employees: 501-1,000 | Worthing, United Kingdom | 501-1,000 | Exact match | 349 contacts → |
“Allergy Therapeutics is a visionary immunology business with specialist experience in the research and development of allergy treatments.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 3 |  Quell Therapeuticsquell-tx.comHQ: London, United KingdomReported employees: 51-200 | London, United Kingdom | 51-200 | Exact match | 157 contacts → |
“An exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 4 |  Enara BIOenarabio.comHQ: Oxford, United KingdomReported employees: 51-200 | Oxford, United Kingdom | 51-200 | Exact match | 63 contacts → |
“Enara Bio is shining a light on Dark Antigen and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients…” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 5 |  Achilles Therapeutics PLCachillestx.comHQ: Hammersmith, United KingdomReported employees: 201-500 | Hammersmith, United Kingdom | 201-500 | Exact match | 63 contacts → |
“Achilles Therapeutics’ mission is to develop next-generation, patient-specific therapies that harness the immune system to destroy cancer cells.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 6 |  T-Therapeutics LTDt-therapeutics.comHQ: Cambridge, United KingdomReported employees: 51-200 | Cambridge, United Kingdom | 51-200 | Exact match | 61 contacts → |
“T-Therapeutics is a next-generation TCR company, spun out from the University of Cambridge, deeply rooted in world-leading academic science.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 7 |  Oxford Biotherapeuticsoxfordbiotherapeutics.comHQ: Oxford, United KingdomReported employees: 11-50 | Oxford, United Kingdom | 11-50 | Exact match | 59 contacts → |
“Oxford BioTherapeutics (OBT) is a clinical stage oncology company based in Oxford, UK; San Jose, CA and Morristown, NJ, USA, with a pipeline of first-in-class immuno-oncology (IO)…” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 8 |  Scancellscancell.co.ukHQ: Oxford, United KingdomReported employees: 51-200 | Oxford, United Kingdom | 51-200 | Exact match | 52 contacts → |
“Scancell is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 9 |  Sitryxsitryx.comHQ: Oxford, United KingdomReported employees: 11-50 | Oxford, United Kingdom | 11-50 | Exact match | 51 contacts → |
“Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 10 |  Gylden Pharmagyldenpharma.comHQ: Abingdon, United KingdomReported employees: 11-50 | Abingdon, United Kingdom | 11-50 | Exact match | 36 contacts → |
“Gylden is a clinical-stage, privately held biotechnology company, headquartered in Abingdon, Oxfordshire, UK, with R&D and GMP manufacturing facilities in Milton Park…” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 11 |  Infinitopesinfinitopes.comHQ: Oxford, United KingdomReported employees: 11-50 | Oxford, United Kingdom | 11-50 | Exact match | 32 contacts → |
“Infinitopes is a pioneer in precision immunomics medicines.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 12 |  TC Biopharmtcbiopharm.comHQ: Holytown, United KingdomReported employees: 51-200 | Holytown, United Kingdom | 51-200 | Exact match | 28 contacts → |
“TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing…” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 13 |  Epsilogen LTDepsilogen.comHQ: United KingdomReported employees: 11-50 | United Kingdom | 11-50 | Exact match | 27 contacts → |
“Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 14 |  Centauri Therapeutics Limitedcentauritherapeutics.comHQ: London, United KingdomReported employees: 1-10 | London, United Kingdom | 1-10 | Exact match | 22 contacts → |
“Centauri Therapeutics Limited is a UK-based biotechnology company focused on the discovery and development of novel molecules targeting life threatening diseases.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 15 |  Yellowstone Biosciencesyellowstonebio.comHQ: Oxford, United KingdomReported employees: 11-50 | Oxford, United Kingdom | 11-50 | Exact match | 22 contacts → |
“Yellowstone aims to unlock a new class of therapeutically targetable frequently expressed antigens with potential to significantly transform patient lives.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 16 |  Leucid BIOleucid.comHQ: London, United KingdomReported employees: 11-50 | London, United Kingdom | 11-50 | Exact match | 21 contacts → |
“Leucid is progressing novel CAR T therapies that produce a better and more durable response than previous CAR T generations, improving treatment outcomes and saving the lives of…” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 17 |  Lift Biosciencesliftbiosciences.comHQ: London, United KingdomReported employees: 11-50 | London, United Kingdom | 11-50 | Exact match | 20 contacts → |
“LIFT BioSciences is pioneering a new class of immunotherapy for hard-to-treat cancers based on allogeneic Immuno-Modulatory Alpha Neutrophils (IMANs)®.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 18 |  Prokariumprokarium.comHQ: London, United KingdomReported employees: 11-50 | London, United Kingdom | 11-50 | Exact match | 19 contacts → |
“Prokarium is pioneering the field of microbial immunotherapy.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 19 |  Neophore LTDneophore.comHQ: London, United KingdomReported employees: 11-50 | London, United Kingdom | 11-50 | Exact match | 18 contacts → |
“Broadening cancer patient access to powerful disease-transforming immunotherapy.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 20 |  Crescendo Biologics Limitedcrescendobiologics.comHQ: Cambridge, United KingdomReported employees: 11-50 | Cambridge, United Kingdom | 11-50 | Exact match | 18 contacts → |
“Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 21 |  Cumulus Oncologycumulusoncology.comHQ: Edinburgh, United KingdomReported employees: 1-10 | Edinburgh, United Kingdom | 1-10 | Exact match | 17 contacts → |
“Cumulus Oncology is developing anti-cancer therapies for clinical settings in areas of high unmet need, with the aim of developing improved outcomes for cancer patients.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 22 |  4bio Capital4biocapital.comHQ: London, United KingdomReported employees: 11-50 | London, United Kingdom | 11-50 | Exact match | 16 contacts → |
“4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 23 |  RQ Biotechnology LTDrqbiotechnology.comHQ: London, United KingdomReported employees: 1-10 | London, United Kingdom | 1-10 | Exact match | 16 contacts → |
“RQ Biotechnology is making instant immunity a reality for vulnerable people.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 24 |  Exogeneexogene.co.ukHQ: Oxford, United KingdomReported employees: 1-10 | Oxford, United Kingdom | 1-10 | Exact match | 15 contacts → |
“Exogene is an Oxford-based, venture-backed biotechnology company using a proprietary lab-in-the-loop AI platform to design novel, multi-specific immune engager drugs targeting…” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 25 |  Poolbeg Pharma PLCpoolbegpharma.comHQ: London, United KingdomReported employees: 11-50 | London, United Kingdom | 11-50 | Exact match | 13 contacts → |
“Poolbeg Pharma plc (AIM: POLB) is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
Showing 25 of 77 company matches
Build a targeted audience, find relevant contacts and export available records to your workflow.
Free signup · 500 credits · limited free results
Immunotherapy venture capital companies: dataset insights
September 3, 2026These summaries describe recorded coverage in this saved dataset. Coverage describes records in RevenueBase, rather than a census of every business in this market.
Reported company sizes
76 records in the displayed employee bands.
1 matching records are outside the displayed bands or do not have a displayed size. Bars show shares of the displayed bands.
Freshness & accuracy
How recently the business emails on this list were verified
Email last verified
How this company list was built
Describe a niche in your own words: companies installing commercial solar, or manufacturers of sustainable packaging. RevenueBase SmartSearch finds companies whose compiled business descriptions match by meaning. This list is one saved example to adapt.
Where the company descriptions come from
RevenueBase compiles company information from public sources, including company websites and public professional profiles such as LinkedIn, alongside information supplied by companies. The short recorded excerpt shown here is separate from the complete business description used for matching; individual source URLs and collection dates are not provided in this public snapshot.
RevenueBase SmartSearch matching settings
- Exact
- Closest fits to the business described.
- Similar
- Similar businesses with a wider range of fits.
- Related
- Related businesses in and around the category.
- Broad
- A broader set of businesses connected to the description.
RevenueBase SmartSearch · Exact match identifies inclusion in this search's closest semantic matching setting. It is not a per-company confidence score, a literal keyword match, or a quality endorsement.
Selection, ordering and scope
The public list shows selected company records with contact and verified-email coverage. Reported employee bands provide separate company-size context.
Coverage describes records in RevenueBase, rather than a census of every business in this market.
Recorded company descriptions support research; check company websites for current services. The selected preview is ordered by tracked contacts and is not a list of the best service providers.
Snapshot: September 3, 2026.
RevenueBase is a B2B data infrastructure company. Its September 3, 2026 published methodology describes a graph of 60 million companies and 398.9 million professional contacts; these platform figures differ from this page's totals. Published methodology ↗
Immunotherapy venture capital companies by metro
Questions about this company list
What does Exact match mean for immunotherapy venture capital companies?
The separate RevenueBase SmartSearch column identifies inclusion at the closest semantic matching preset. It is not a literal keyword match, a per-company confidence score or a quality endorsement. Changing the search form opens a new search in RevenueBase; it does not reclassify these saved rows.
How many immunotherapy venture capital companies did RevenueBase find based in the United Kingdom?
The saved snapshot records 77 matching company records, 2,304 tracked contacts and 1,356 verified emails. The public preview displays 25 selected records.
Where do the company descriptions come from?
RevenueBase compiles company information from public sources, including company websites and public professional profiles such as LinkedIn, alongside information supplied by companies. The short recorded excerpt shown here is separate from the complete business description used for matching; individual source URLs and collection dates are not provided in this public snapshot.
How are the public companies ordered?
The selected public records are ordered by contacts tracked in RevenueBase, highest first. Contact coverage is a prospecting measure, not an assessment of the company's services or quality.
How can I get contact information?
Select a company's contact count to open its filtered contacts in RevenueBase. Free signup is required and includes 500 credits and limited free results. Verified emails, direct dials and mobile numbers depend on available coverage.
How current is this list?
Snapshot: September 3, 2026. Review each company's website for current services and locations. A recorded business description does not establish that every company offers every service named in the search.
What do headquarters and employee bands mean?
These are recorded company-level fields, rather than a map of every branch or a count of specialists. Missing headquarters or employee bands are labeled; older records may show a location separately from recorded headquarters.
Build your next target company list
Adapt this niche search and work with available contacts in RevenueBase.
Related lists
Immunotherapy venture capital companies by geography
- Immunotherapy venture capital companies based in the United States
- Immunotherapy venture capital companies based in France
- Immunotherapy venture capital companies based in Germany
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland
- Immunotherapy venture capital companies based in Australia
- Immunotherapy venture capital companies based in Spain
- Immunotherapy venture capital companies based in London, United Kingdom
- Immunotherapy venture capital companies based in Boston, United States
- Immunotherapy venture capital companies based in Cambridge, United States
- Immunotherapy venture capital companies based in New York, United States
- Immunotherapy venture capital companies based in San Diego, United States
Cite this list
RevenueBase Data Team. Top 25 immunotherapy venture capital companies based in the United Kingdom. Snapshot: September 3, 2026. https://revenuebase.ai/companies/immunotherapy-venture-capital-companies/united-kingdom.
This is a selected public preview of saved company records, rather than an independently verified census. Open the source page ↗
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Immunotherapy venture capital companies based in the United States
- Immunotherapy venture capital companies based in France
- Immunotherapy venture capital companies based in Germany
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland
- Immunotherapy venture capital companies based in Australia
Company intelligence · public preview
Top 25 immunotherapy venture capital companies based in the United Kingdom
RevenueBase records 77 matching company records for immunotherapy venture capital companies based in the United Kingdom, with 2,304 tracked contacts and 1,356 verified work emails.
This public preview shows 25 selected records ordered by tracked contacts. RevenueBase SmartSearch finds company descriptions that match by meaning at Exact. Snapshot: September 3, 2026.
RevenueBase compiles business descriptions for niche-company discovery; each row shows a recorded excerpt where available. Adapt this search to find the companies and contacts you want.
Top 25 immunotherapy venture capital companies based in the United Kingdom
The public list shows selected company records with contact and verified-email coverage. Reported employee bands provide separate company-size context.
| # | Company | Headquarters on record | Reported employees | RevenueBase SmartSearch | Tracked contacts |
|---|---|---|---|---|---|
| 1 | Autolus Therapeuticsautolus.com HQ: London, United KingdomReported employees: 501-1,000 | London, United Kingdom | 501-1,000 | Exact match | 763 contacts → |
“Autolus is a CAR T cell therapy company.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 2 | Allergy Therapeuticsallergytherapeutics.com HQ: Worthing, United KingdomReported employees: 501-1,000 | Worthing, United Kingdom | 501-1,000 | Exact match | 349 contacts → |
“Allergy Therapeutics is a visionary immunology business with specialist experience in the research and development of allergy treatments.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 3 | Quell Therapeuticsquell-tx.com HQ: London, United KingdomReported employees: 51-200 | London, United Kingdom | 51-200 | Exact match | 157 contacts → |
“An exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 4 | Enara BIOenarabio.com HQ: Oxford, United KingdomReported employees: 51-200 | Oxford, United Kingdom | 51-200 | Exact match | 63 contacts → |
“Enara Bio is shining a light on Dark Antigen and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients…” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 5 | Achilles Therapeutics PLCachillestx.com HQ: Hammersmith, United KingdomReported employees: 201-500 | Hammersmith, United Kingdom | 201-500 | Exact match | 63 contacts → |
“Achilles Therapeutics’ mission is to develop next-generation, patient-specific therapies that harness the immune system to destroy cancer cells.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 6 | T-Therapeutics LTDt-therapeutics.com HQ: Cambridge, United KingdomReported employees: 51-200 | Cambridge, United Kingdom | 51-200 | Exact match | 61 contacts → |
“T-Therapeutics is a next-generation TCR company, spun out from the University of Cambridge, deeply rooted in world-leading academic science.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 7 | Oxford Biotherapeuticsoxfordbiotherapeutics.com HQ: Oxford, United KingdomReported employees: 11-50 | Oxford, United Kingdom | 11-50 | Exact match | 59 contacts → |
“Oxford BioTherapeutics (OBT) is a clinical stage oncology company based in Oxford, UK; San Jose, CA and Morristown, NJ, USA, with a pipeline of first-in-class immuno-oncology (IO)…” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 8 | Scancellscancell.co.uk HQ: Oxford, United KingdomReported employees: 51-200 | Oxford, United Kingdom | 51-200 | Exact match | 52 contacts → |
“Scancell is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 9 | Sitryxsitryx.com HQ: Oxford, United KingdomReported employees: 11-50 | Oxford, United Kingdom | 11-50 | Exact match | 51 contacts → |
“Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 10 | Gylden Pharmagyldenpharma.com HQ: Abingdon, United KingdomReported employees: 11-50 | Abingdon, United Kingdom | 11-50 | Exact match | 36 contacts → |
“Gylden is a clinical-stage, privately held biotechnology company, headquartered in Abingdon, Oxfordshire, UK, with R&D and GMP manufacturing facilities in Milton Park…” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 11 | Infinitopesinfinitopes.com HQ: Oxford, United KingdomReported employees: 11-50 | Oxford, United Kingdom | 11-50 | Exact match | 32 contacts → |
“Infinitopes is a pioneer in precision immunomics medicines.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 12 | TC Biopharmtcbiopharm.com HQ: Holytown, United KingdomReported employees: 51-200 | Holytown, United Kingdom | 51-200 | Exact match | 28 contacts → |
“TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing…” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 13 | Epsilogen LTDepsilogen.com HQ: United KingdomReported employees: 11-50 | United Kingdom | 11-50 | Exact match | 27 contacts → |
“Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 14 | Centauri Therapeutics Limitedcentauritherapeutics.com HQ: London, United KingdomReported employees: 1-10 | London, United Kingdom | 1-10 | Exact match | 22 contacts → |
“Centauri Therapeutics Limited is a UK-based biotechnology company focused on the discovery and development of novel molecules targeting life threatening diseases.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 15 | Yellowstone Biosciencesyellowstonebio.com HQ: Oxford, United KingdomReported employees: 11-50 | Oxford, United Kingdom | 11-50 | Exact match | 22 contacts → |
“Yellowstone aims to unlock a new class of therapeutically targetable frequently expressed antigens with potential to significantly transform patient lives.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 16 | Leucid BIOleucid.com HQ: London, United KingdomReported employees: 11-50 | London, United Kingdom | 11-50 | Exact match | 21 contacts → |
“Leucid is progressing novel CAR T therapies that produce a better and more durable response than previous CAR T generations, improving treatment outcomes and saving the lives of…” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 17 | Lift Biosciencesliftbiosciences.com HQ: London, United KingdomReported employees: 11-50 | London, United Kingdom | 11-50 | Exact match | 20 contacts → |
“LIFT BioSciences is pioneering a new class of immunotherapy for hard-to-treat cancers based on allogeneic Immuno-Modulatory Alpha Neutrophils (IMANs)®.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 18 | Prokariumprokarium.com HQ: London, United KingdomReported employees: 11-50 | London, United Kingdom | 11-50 | Exact match | 19 contacts → |
“Prokarium is pioneering the field of microbial immunotherapy.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 19 | Neophore LTDneophore.com HQ: London, United KingdomReported employees: 11-50 | London, United Kingdom | 11-50 | Exact match | 18 contacts → |
“Broadening cancer patient access to powerful disease-transforming immunotherapy.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 20 | Crescendo Biologics Limitedcrescendobiologics.com HQ: Cambridge, United KingdomReported employees: 11-50 | Cambridge, United Kingdom | 11-50 | Exact match | 18 contacts → |
“Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 21 | Cumulus Oncologycumulusoncology.com HQ: Edinburgh, United KingdomReported employees: 1-10 | Edinburgh, United Kingdom | 1-10 | Exact match | 17 contacts → |
“Cumulus Oncology is developing anti-cancer therapies for clinical settings in areas of high unmet need, with the aim of developing improved outcomes for cancer patients.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 22 | 4bio Capital4biocapital.com HQ: London, United KingdomReported employees: 11-50 | London, United Kingdom | 11-50 | Exact match | 16 contacts → |
“4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 23 | RQ Biotechnology LTDrqbiotechnology.com HQ: London, United KingdomReported employees: 1-10 | London, United Kingdom | 1-10 | Exact match | 16 contacts → |
“RQ Biotechnology is making instant immunity a reality for vulnerable people.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 24 | Exogeneexogene.co.uk HQ: Oxford, United KingdomReported employees: 1-10 | Oxford, United Kingdom | 1-10 | Exact match | 15 contacts → |
“Exogene is an Oxford-based, venture-backed biotechnology company using a proprietary lab-in-the-loop AI platform to design novel, multi-specific immune engager drugs targeting…” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
| 25 | Poolbeg Pharma PLCpoolbegpharma.com HQ: London, United KingdomReported employees: 11-50 | London, United Kingdom | 11-50 | Exact match | 13 contacts → |
“Poolbeg Pharma plc (AIM: POLB) is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field.” Recorded description excerpt · September 3, 2026Open company data in RevenueBase ↗Free signup required. | |||||
Showing 25 of 77 company matches
Build a targeted audience, find relevant contacts and export available records to your workflow.
Free signup · 500 credits · limited free results
Immunotherapy venture capital companies: dataset insights
September 3, 2026These summaries describe recorded coverage in this saved dataset. Coverage describes records in RevenueBase, rather than a census of every business in this market.
Reported company sizes
76 records in the displayed employee bands.
1 matching records are outside the displayed bands or do not have a displayed size. Bars show shares of the displayed bands.
Freshness & accuracy
How recently the business emails on this list were verified
Email last verified
How this company list was built
Describe a niche in your own words: companies installing commercial solar, or manufacturers of sustainable packaging. RevenueBase SmartSearch finds companies whose compiled business descriptions match by meaning. This list is one saved example to adapt.
Where the company descriptions come from
RevenueBase compiles company information from public sources, including company websites and public professional profiles such as LinkedIn, alongside information supplied by companies. The short recorded excerpt shown here is separate from the complete business description used for matching; individual source URLs and collection dates are not provided in this public snapshot.
RevenueBase SmartSearch matching settings
- Exact
- Closest fits to the business described.
- Similar
- Similar businesses with a wider range of fits.
- Related
- Related businesses in and around the category.
- Broad
- A broader set of businesses connected to the description.
RevenueBase SmartSearch · Exact match identifies inclusion in this search's closest semantic matching setting. It is not a per-company confidence score, a literal keyword match, or a quality endorsement.
Selection, ordering and scope
The public list shows selected company records with contact and verified-email coverage. Reported employee bands provide separate company-size context.
Coverage describes records in RevenueBase, rather than a census of every business in this market.
Recorded company descriptions support research; check company websites for current services. The selected preview is ordered by tracked contacts and is not a list of the best service providers.
Snapshot: September 3, 2026.
RevenueBase is a B2B data infrastructure company. Its September 3, 2026 published methodology describes a graph of 60 million companies and 398.9 million professional contacts; these platform figures differ from this page's totals. Published methodology ↗
Immunotherapy venture capital companies by metro
Questions about this company list
What does Exact match mean for immunotherapy venture capital companies?
The separate RevenueBase SmartSearch column identifies inclusion at the closest semantic matching preset. It is not a literal keyword match, a per-company confidence score or a quality endorsement. Changing the search form opens a new search in RevenueBase; it does not reclassify these saved rows.
How many immunotherapy venture capital companies did RevenueBase find based in the United Kingdom?
The saved snapshot records 77 matching company records, 2,304 tracked contacts and 1,356 verified emails. The public preview displays 25 selected records.
Where do the company descriptions come from?
RevenueBase compiles company information from public sources, including company websites and public professional profiles such as LinkedIn, alongside information supplied by companies. The short recorded excerpt shown here is separate from the complete business description used for matching; individual source URLs and collection dates are not provided in this public snapshot.
How are the public companies ordered?
The selected public records are ordered by contacts tracked in RevenueBase, highest first. Contact coverage is a prospecting measure, not an assessment of the company's services or quality.
How can I get contact information?
Select a company's contact count to open its filtered contacts in RevenueBase. Free signup is required and includes 500 credits and limited free results. Verified emails, direct dials and mobile numbers depend on available coverage.
How current is this list?
Snapshot: September 3, 2026. Review each company's website for current services and locations. A recorded business description does not establish that every company offers every service named in the search.
What do headquarters and employee bands mean?
These are recorded company-level fields, rather than a map of every branch or a count of specialists. Missing headquarters or employee bands are labeled; older records may show a location separately from recorded headquarters.
Build your next target company list
Adapt this niche search and work with available contacts in RevenueBase.
Related lists
Immunotherapy venture capital companies by geography
- Immunotherapy venture capital companies based in the United States
- Immunotherapy venture capital companies based in France
- Immunotherapy venture capital companies based in Germany
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland
- Immunotherapy venture capital companies based in Australia
- Immunotherapy venture capital companies based in Spain
- Immunotherapy venture capital companies based in London, United Kingdom
- Immunotherapy venture capital companies based in Boston, United States
- Immunotherapy venture capital companies based in Cambridge, United States
- Immunotherapy venture capital companies based in New York, United States
- Immunotherapy venture capital companies based in San Diego, United States
Cite this list
RevenueBase Data Team. Top 25 immunotherapy venture capital companies based in the United Kingdom. Snapshot: September 3, 2026. https://revenuebase.ai/companies/immunotherapy-venture-capital-companies/united-kingdom.
This is a selected public preview of saved company records, rather than an independently verified census. Open the source page ↗
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Immunotherapy venture capital companies based in the United States
- Immunotherapy venture capital companies based in France
- Immunotherapy venture capital companies based in Germany
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland
- Immunotherapy venture capital companies based in Australia